153 related articles for article (PubMed ID: 16321988)
1. Association of the truncating splice site mutation in BTNL2 with multiple sclerosis is secondary to HLA-DRB1*15.
Traherne JA; Barcellos LF; Sawcer SJ; Compston A; Ramsay PP; Hauser SL; Oksenberg JR; Trowsdale J
Hum Mol Genet; 2006 Jan; 15(1):155-61. PubMed ID: 16321988
[TBL] [Abstract][Full Text] [Related]
2. Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.
Spagnolo P; Sato H; Grutters JC; Renzoni EA; Marshall SE; Ruven HJ; Wells AU; Tzouvelekis A; van Moorsel CH; van den Bosch JM; du Bois RM; Welsh KI
Tissue Antigens; 2007 Sep; 70(3):219-27. PubMed ID: 17661910
[TBL] [Abstract][Full Text] [Related]
3. Butyrophilin-like 2 gene is associated with ulcerative colitis in the Japanese under strong linkage disequilibrium with HLA-DRB1*1502.
Mochida A; Kinouchi Y; Negoro K; Takahashi S; Takagi S; Nomura E; Kakuta Y; Tosa M; Shimosegawa T
Tissue Antigens; 2007 Aug; 70(2):128-35. PubMed ID: 17610417
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the BTNL2 truncating splice site mutation in tuberculosis, leprosy and Crohn's disease.
Johnson CM; Traherne JA; Jamieson SE; Tremelling M; Bingham S; Parkes M; Blackwell JM; Trowsdale J
Tissue Antigens; 2007 Mar; 69(3):236-41. PubMed ID: 17493147
[TBL] [Abstract][Full Text] [Related]
5. Genetic characterization and susceptibility for sarcoidosis in Japanese patients: risk factors of BTNL2 gene polymorphisms and HLA class II alleles.
Suzuki H; Ota M; Meguro A; Katsuyama Y; Kawagoe T; Ishihara M; Asukata Y; Takeuchi M; Ito N; Shibuya E; Nomura E; Uemoto R; Nishide T; Namba K; Kitaichi N; Morimoto S; Kaburaki T; Ando Y; Takenaka S; Nakamura J; Saeki K; Ohno S; Inoko H; Mizuki N
Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):7109-15. PubMed ID: 22991420
[TBL] [Abstract][Full Text] [Related]
6. Association of the BTNL2 rs2076530 single nucleotide polymorphism with Graves' disease appears to be secondary to DRB1 exon 2 position beta74.
Simmonds MJ; Heward JM; Barrett JC; Franklyn JA; Gough SC
Clin Endocrinol (Oxf); 2006 Oct; 65(4):429-32. PubMed ID: 16984233
[TBL] [Abstract][Full Text] [Related]
7. Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis.
Caillier SJ; Briggs F; Cree BA; Baranzini SE; Fernandez-Viña M; Ramsay PP; Khan O; Royal W; Hauser SL; Barcellos LF; Oksenberg JR
J Immunol; 2008 Oct; 181(8):5473-80. PubMed ID: 18832704
[TBL] [Abstract][Full Text] [Related]
8. Sarcoidosis is associated with a truncating splice site mutation in BTNL2.
Valentonyte R; Hampe J; Huse K; Rosenstiel P; Albrecht M; Stenzel A; Nagy M; Gaede KI; Franke A; Haesler R; Koch A; Lengauer T; Seegert D; Reiling N; Ehlers S; Schwinger E; Platzer M; Krawczak M; Müller-Quernheim J; Schürmann M; Schreiber S
Nat Genet; 2005 Apr; 37(4):357-64. PubMed ID: 15735647
[TBL] [Abstract][Full Text] [Related]
9. Mapping multiple sclerosis susceptibility to the HLA-DR locus in African Americans.
Oksenberg JR; Barcellos LF; Cree BA; Baranzini SE; Bugawan TL; Khan O; Lincoln RR; Swerdlin A; Mignot E; Lin L; Goodin D; Erlich HA; Schmidt S; Thomson G; Reich DE; Pericak-Vance MA; Haines JL; Hauser SL
Am J Hum Genet; 2004 Jan; 74(1):160-7. PubMed ID: 14669136
[TBL] [Abstract][Full Text] [Related]
10. The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites.
Rybicki BA; Walewski JL; Maliarik MJ; Kian H; Iannuzzi MC;
Am J Hum Genet; 2005 Sep; 77(3):491-9. PubMed ID: 16080124
[TBL] [Abstract][Full Text] [Related]
11. Analysis of extended HLA haplotypes in multiple sclerosis and narcolepsy families confirms a predisposing effect for the class I region in Tasmanian MS patients.
Rubio JP; Bahlo M; Stankovich J; Burfoot RK; Johnson LJ; Huxtable S; Butzkueven H; Lin L; Taylor BV; Speed TP; Kilpatrick TJ; Mignot E; Foote SJ
Immunogenetics; 2007 Mar; 59(3):177-86. PubMed ID: 17256150
[TBL] [Abstract][Full Text] [Related]
12. Evidence for the genetic role of human leukocyte antigens in low frequency DRB1*1501 multiple sclerosis patients in Israel.
Karni A; Kohn Y; Safirman C; Abramsky O; Barcellos L; Oksenberg JR; Kahana E; Karussis D; Chapman J; Brautbar C
Mult Scler; 1999 Dec; 5(6):410-5. PubMed ID: 10618697
[TBL] [Abstract][Full Text] [Related]
13. Evidence for a complex role of HLA class II genotypes in susceptibility to multiple sclerosis in Iceland.
Haegert DG; Swift FV; Benedikz J
Neurology; 1996 Apr; 46(4):1107-11. PubMed ID: 8780100
[TBL] [Abstract][Full Text] [Related]
14. DRB1-DQA1-DQB1 loci and multiple sclerosis predisposition in the Sardinian population.
Marrosu MG; Murru MR; Costa G; Murru R; Muntoni F; Cucca F
Hum Mol Genet; 1998 Aug; 7(8):1235-7. PubMed ID: 9668164
[TBL] [Abstract][Full Text] [Related]
15. A major histocompatibility Class I locus contributes to multiple sclerosis susceptibility independently from HLA-DRB1*15:01.
Cree BA; Rioux JD; McCauley JL; Gourraud PA; Goyette P; McElroy J; De Jager P; Santaniello A; Vyse TJ; Gregersen PK; Mirel D; Hafler DA; Haines JL; Pericak-Vance MA; Compston A; Sawcer SJ; Oksenberg JR; Hauser SL; ;
PLoS One; 2010 Jun; 5(6):e11296. PubMed ID: 20593013
[TBL] [Abstract][Full Text] [Related]
16. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals.
Sato H; Spagnolo P; Silveira L; Welsh KI; du Bois RM; Newman LS; Maier LA
Tissue Antigens; 2007 Dec; 70(6):480-6. PubMed ID: 17927685
[TBL] [Abstract][Full Text] [Related]
17. BTNL2 gene polymorphism associations with susceptibility and phenotype expression in sarcoidosis.
Morais A; Lima B; Peixoto MJ; Alves H; Marques A; Delgado L
Respir Med; 2012 Dec; 106(12):1771-7. PubMed ID: 23017494
[TBL] [Abstract][Full Text] [Related]
18. Association of susceptibility to multiple sclerosis in Sweden with HLA class II DRB1 and DQB1 alleles.
Allen M; Sandberg-Wollheim M; Sjögren K; Erlich HA; Petterson U; Gyllensten U
Hum Immunol; 1994 Jan; 39(1):41-8. PubMed ID: 8181961
[TBL] [Abstract][Full Text] [Related]
19. Evidence of linkage with HLA-DR in DRB1*15-negative families with multiple sclerosis.
Ligers A; Dyment DA; Willer CJ; Sadovnick AD; Ebers G; Risch N; Hillert J;
Am J Hum Genet; 2001 Oct; 69(4):900-3. PubMed ID: 11519010
[TBL] [Abstract][Full Text] [Related]
20. HLA-DQB1*0602 determines disease susceptibility in a new "humanized" multiple sclerosis model in HLA-DR15 (DRB1*1501;DQB1*0602) transgenic mice.
Kaushansky N; Altmann DM; Ascough S; David CS; Lassmann H; Ben-Nun A
J Immunol; 2009 Sep; 183(5):3531-41. PubMed ID: 19648275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
